NEU 6.41% $15.27 neuren pharmaceuticals limited

Ann: Trofinetide successful in Phase 2 trial in Fragile X, page-71

  1. 1,293 Posts.
    lightbulb Created with Sketch. 318
    To all stressing about lack of volume and movement, don't sweat it. We all know how unsophisticated the ASX is relative to our American and UK equivalents. The market will wake up in time and our rewards will indeed be handsome...In the meantime spend your time chillin' out, maxing, relaxing all cool...
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.